Koa Shoji Holdings Co.,Ltd. (9273.T)
JPY 611.0
(2.0%)
JPY 611.0
(2.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.26 Billion JPY | -7.96% |
| 2022 | 2.46 Billion JPY | 7.5% |
| 2021 | 2.29 Billion JPY | 7.24% |
| 2020 | 2.13 Billion JPY | 7.59% |
| 2019 | 1.98 Billion JPY | 28.73% |
| 2018 | 1.54 Billion JPY | 22.26% |
| 2017 | 1.26 Billion JPY | 2.07% |
| 2016 | 1.23 Billion JPY | 18.35% |
| 2015 | 1.04 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | 2.55 Billion JPY | 3.65% |
| 2023 FY | 2.26 Billion JPY | -7.96% |
| 2023 Q2 | 2.5 Billion JPY | -1.77% |
| 2023 Q4 | 2.26 Billion JPY | -14.09% |
| 2023 Q3 | 2.63 Billion JPY | 5.24% |
| 2022 Q3 | 3.07 Billion JPY | 14.52% |
| 2022 Q2 | 2.68 Billion JPY | -1.29% |
| 2022 Q1 | 2.72 Billion JPY | 18.77% |
| 2022 FY | 2.46 Billion JPY | 7.5% |
| 2022 Q4 | 2.46 Billion JPY | -19.92% |
| 2021 Q3 | 2.57 Billion JPY | 15.31% |
| 2021 FY | 2.29 Billion JPY | 7.24% |
| 2021 Q1 | 2.52 Billion JPY | 18.44% |
| 2021 Q4 | 2.29 Billion JPY | -10.91% |
| 2021 Q2 | 2.22 Billion JPY | -11.87% |
| 2020 Q2 | 2.17 Billion JPY | 18.6% |
| 2020 FY | 2.13 Billion JPY | 7.59% |
| 2020 Q1 | 1.83 Billion JPY | -7.69% |
| 2020 Q4 | 2.13 Billion JPY | -12.01% |
| 2020 Q3 | 2.42 Billion JPY | 11.68% |
| 2019 Q3 | 2.34 Billion JPY | 20.06% |
| 2019 FY | 1.98 Billion JPY | 28.73% |
| 2019 Q1 | 1.95 Billion JPY | 26.5% |
| 2019 Q2 | 1.95 Billion JPY | -0.0% |
| 2019 Q4 | 1.98 Billion JPY | -15.23% |
| 2018 Q2 | 1.74 Billion JPY | 15.31% |
| 2018 FY | 1.54 Billion JPY | 22.26% |
| 2018 Q4 | 1.54 Billion JPY | -28.26% |
| 2018 Q3 | 2.14 Billion JPY | 23.18% |
| 2018 Q1 | 1.51 Billion JPY | 19.99% |
| 2017 Q3 | 1.8 Billion JPY | 0.0% |
| 2017 FY | 1.26 Billion JPY | 2.07% |
| 2017 Q4 | 1.26 Billion JPY | -30.08% |
| 2016 FY | 1.23 Billion JPY | 18.35% |
| 2015 FY | 1.04 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | 66.261% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.813% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 98.035% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 96.509% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -12.972% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 94.206% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 86.799% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 98.702% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | 28.846% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 89.298% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 92.515% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 84.043% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 78.863% |
| Tsumura & Co. | 117.61 Billion JPY | 98.073% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 91.382% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 78.903% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 97.758% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 88.301% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 84.36% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 95.762% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -16.099% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 89.151% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -876.709% |
| MedRx Co., Ltd | 10 Million JPY | -22562.58% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -41.942% |
| Solasia Pharma K.K. | 122 Million JPY | -1757.589% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -35572.249% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 88.892% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 97.734% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -4821.833% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 97.404% |